CLINICAL_TRIALS
trial_result
· 2020-02-18
Clinical Trial Update: Neoadjuvant Pembrolizumab [Phase 2]
Summary
Phase 2 neoadjuvant trial of pembrolizumab in non-small cell lung cancer has completed. Results were posted on 2020-02-18.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neal Ready MD PhD | Conditions: Non-small Cell Lung Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-02-18